Anemia and Iron Deficiency in Aging: Diagnosis, Causes, and Supplementation Evidence

Anemia — defined as hemoglobin below 12 g/dL in women and below 13 g/dL in men — is not a normal part of aging, but it is common. Prevalence rises from approximately 10% in community-dwelling adults aged 65-74 to 20% or more in those over 85. Among hospitalized and institutionalized older adults, rates reach 30-40%.

Anemia in older adults carries independent risk: it is associated with reduced physical performance, increased fall risk, cognitive impairment, hospitalization, and mortality. A 2013 meta-analysis of prospective studies found that anemia was associated with a 2-3 fold increased risk of dementia in older adults. Treating underlying causes often improves function markedly — fatigue, cognitive fog, and exercise intolerance frequently resolve with correction.

Causes: Anemia Is Usually Multifactorial in Older Adults

The World Health Organization estimated that iron deficiency accounts for approximately half of all anemia globally, but in older adults the cause distribution is substantially different. A landmark epidemiological analysis (NHANES III) found that in adults over 65:

• Nutritional deficiency (iron, B12, folate): approximately 34% of cases
• Anemia of chronic disease (ACD/AI): approximately 32% of cases
• Unexplained anemia of aging: approximately 26% of cases
• Renal anemia (erythropoietin deficiency): a significant proportion of "unexplained" cases

This distribution has critical implications: administering iron supplementation to an older adult with anemia of chronic disease (where iron is trapped, not deficient) can worsen outcomes — excess iron drives oxidative stress and bacterial growth. Identifying the cause before supplementing is essential.

Diagnosing Iron Deficiency in Older Adults

Ferritin is the primary diagnostic marker for iron stores, but its interpretation in older adults requires nuance. Ferritin is an acute-phase reactant — it rises with inflammation, infection, malignancy, and liver disease. A "normal" ferritin in the context of systemic inflammation does not rule out functional iron deficiency.

Diagnostic interpretation:

• Serum ferritin below 30 mcg/L: high probability of iron deficiency
• Ferritin 30-100 mcg/L with elevated CRP: iron deficiency may be masked by inflammation; additional markers needed
• Transferrin saturation (TSAT) below 20%: supports iron deficiency diagnosis
• Soluble transferrin receptor (sTfR): elevated in iron deficiency; not affected by inflammation — more specific than ferritin in inflammatory states

Complete blood count findings in iron deficiency anemia:

• Low mean corpuscular volume (MCV), typically below 80 fL
• Low mean corpuscular hemoglobin (MCH)
• Elevated red blood cell distribution width (RDW)
• Reticulocyte count may be low-normal

Vitamin B12 and folate deficiency should always be tested alongside iron — they produce macrocytic anemia (high MCV) and overlap in symptoms. B12 deficiency is common in older adults due to reduced gastric acid and intrinsic factor production; pernicious anemia (autoimmune cause) has its highest incidence in women over 60.

Finding the Cause of Iron Deficiency

Iron deficiency in postmenopausal women or any man should prompt investigation of the cause. In older adults, gastrointestinal blood loss (from peptic ulcer disease, colorectal cancer, angiodysplasia, or medications including NSAIDs and aspirin) accounts for a large proportion of iron deficiency. Symptomatic iron deficiency in a postmenopausal woman or any man over 50 warrants upper and lower GI evaluation to rule out occult bleeding.

Dietary iron intake is rarely the sole cause of iron deficiency in older adults unless food intake is severely restricted. Poor iron absorption due to hypochlorhydria (very common with proton pump inhibitor use or atrophic gastritis, which both increase with age) can contribute.

Iron Supplementation: Evidence and Dosing

When iron deficiency is confirmed, oral iron supplementation reliably corrects hemoglobin within 4-8 weeks and replenishes stores within 3-6 months.

Forms of oral iron:

• Ferrous sulfate: most studied and least expensive; 65mg elemental iron per 325mg tablet; frequently causes GI side effects (nausea, constipation, dark stools)
• Ferrous gluconate: lower elemental iron per tablet (12mg per 300mg tablet); slightly better GI tolerability; requires more tablets
• Ferrous bisglycinate (iron bisglycinate chelate): better absorbed per mg of elemental iron; substantially fewer GI side effects in comparative trials; more expensive; useful for those who cannot tolerate standard ferrous sulfate
• Ferric maltol: newer formulation with good absorption and tolerability, approved for inflammatory bowel disease-associated iron deficiency

Dosing considerations in older adults:

• The traditional twice or three times daily dosing is being revised by pharmacokinetic data: alternate-day dosing (every other day) produces comparable or superior total iron absorption over time by preventing hepcidin upregulation (hepcidin is the hormone that suppresses iron absorption; it rises sharply after an iron dose and takes 24-48 hours to normalize)
• A 2017 AJCN trial confirmed that alternate-day oral iron in iron-deficient women produced superior fractional iron absorption per dose versus daily dosing
• Co-administering with vitamin C (250-500mg) increases non-heme iron absorption 2-3 fold
• Taking separately from calcium, dairy, tea, coffee, and antacids by at least 2 hours optimizes absorption

Intravenous Iron

When oral iron fails (due to malabsorption, severe GI intolerance, or need for rapid correction before surgery), intravenous iron formulations (ferric carboxymaltose, ferumoxytol, iron sucrose) bypass intestinal absorption and reliably correct iron stores within 4-6 weeks. They are appropriate in inflammatory bowel disease, chronic kidney disease with impaired erythropoiesis, and preoperative anemia correction.

B12 Deficiency Anemia: Separate Mechanism

B12 deficiency anemia (megaloblastic anemia) produces large, immature red blood cells due to impaired DNA synthesis. In older adults, the most common causes are:

• Reduced intrinsic factor from atrophic gastritis (food-cobalamin malabsorption)
• Pernicious anemia (autoimmune)
• Metformin use (reduces B12 absorption via ileal receptor competition)
• Proton pump inhibitor use

Treatment: B12 deficiency responds equally well to high-dose oral B12 (1000-2000 mcg/day, which overcomes the impaired intrinsic factor pathway via passive absorption) as to intramuscular injection in most patients. Neurological symptoms (peripheral neuropathy, cognitive changes) may require parenteral B12 at least initially. Monitoring: serum B12, methylmalonic acid, and CBC at 3 and 6 months after treatment initiation.

When Not to Supplement Iron

Iron supplementation is not indicated and may be harmful when:

• Hemoglobin and ferritin are within normal range
• Anemia is due to chronic disease or inflammation (without concurrent iron deficiency)
• Hereditary hemochromatosis is present (genetic disorder of iron overload)
• Renal failure with adequate erythropoiesis-stimulating agent response
• Men with unexplained fatigue alone, without laboratory evidence of deficiency

Iron excess produces oxidative stress via Fenton chemistry, promotes bacterial growth (relevant in infection), and is associated with increased cardiovascular and cancer risk in men with genetic predisposition to iron overload. Routine iron supplementation without testing is not appropriate.

Related pages: Iron, Vitamin C, Vitamin B12, Anemia Iron Deficiency, Sarcopenia Age Related Muscle Loss, Copper Zinc Balance Aging, Biomarker Testing Guide

Evidence Limits and What We Still Need

The "unexplained anemia of aging" category — which accounts for approximately a quarter of anemia in older adults — remains poorly understood. Its pathophysiology likely involves a combination of erythropoietin insensitivity, stem cell aging, and chronic low-grade inflammation, but targeted treatments are not established. The optimal ferritin target for older adults specifically (as opposed to the general population) is debated — some evidence suggests higher targets (above 50-70 mcg/L) may be needed for full symptom resolution. Alternate-day iron dosing is supported by mechanistic pharmacokinetics and one major RCT but has not been tested in large outcome trials in older adults specifically. The cognitive impairment associated with anemia in older adults is well documented in cross-sectional data, but whether correction of anemia improves cognitive outcomes in randomized trials is not yet established.

Sources

1. Guralnik JM, et al. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004. https://pubmed.ncbi.nlm.nih.gov/26869657/
2. Patel KV, et al. Prevalence and type of anemia in early CKD. Am J Kidney Dis. 2008. https://pubmed.ncbi.nlm.nih.gov/25851639/
3. Moretti D, et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood. 2015. https://pubmed.ncbi.nlm.nih.gov/26297742/
4. Hunt JR, et al. Ascorbic acid: effect on ongoing iron absorption and status in iron-depleted young women. Am J Clin Nutr. 1994. https://pubmed.ncbi.nlm.nih.gov/8105089/
5. Carmel R. How I treat cobalamin (vitamin B12) deficiency. Blood. 2008. https://pubmed.ncbi.nlm.nih.gov/18606874/
6. Stauder R, et al. Anemia at older age: etiologies, clinical implications, and management. Blood. 2018. https://pubmed.ncbi.nlm.nih.gov/29959175/